AI for faster, safer, and more effective trials
The first and best speciality oncology focussed AI biomarker company; working with the leading biotech and pharma groups
What we do
Biologically meaningful grouping; beyond molecular subtyping
We identify known and novel biologically-relevant subtypes and categorise trial participants into the appropriate groups with a consistency and precision that current pathology workflows cannot match.
Unique, expert-curated reference cohorts enable us to generate reliable patient stratification even from small trial populations.
Insights to power your trial recruitment, protocol design and in-trial management.
Immediate treatment response and disease progression insights
Systematic, quantitative analysis of samples that accounts for molecular, demographic, and contextual data.
Enable analysis of the entire sample via our heat-mapping of the whole slide to identify areas of interest.
Interpretable and reproducible insights you can trust.
Consistent analysis; super-powering your pathology capabilities
Systematic, quantitative analysis of samples that accounts for molecular, demographic, and contextual data.
Enable analysis of the entire sample via our heat-mapping of the whole slide to identify areas of interest.
Interpretable and reproducible insights you can trust.
Case studies
We have delivered trial-defining insights to world-class biopharma companies
1
Stratify patients at screening
Our platform's blind analysis for a top 5-biopharma identified patients in their trial cohort that had been incorrectly recruited to trial through manual pathology who did not meet inclusion criteria.
Our annotated reference cohorts enrich predictive biomarker development.
2
Consistent analysis; super-powering your pathology capabilities
Systematic, quantitative analysis of samples that accounts for molecular, demographic, and contextual data.
Enable analysis of the entire sample via our heat-mapping of the whole slide to identify areas of interest.
Interpretable and reproducible insights you can trust.
3
Immediate treatment response and disease progression insights
Our workflows enable immediate analysis and contextualisation of your patients without the need for extraneous 3rd party services that delay your pipeline and trial completion.
Enhanced monitoring of treatment-related effects permitting early detection and adaptive response from the trial team to enable safer trials.
Boost your histology,
start using tissue biomarkers today
We're applying tissue biomarkers to trials, research and clinical audits today. Let's talk about custom applications for your project.
Get in touch